Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug: A Review

Author: Del Tacca M.   Colucci R.   Fornai M.   Blandizzi C.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.22, Iss.12, 2002-01, pp. : 799-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract